Chang S D, Adler J R, Martin D P
Departments of Neurosurgery, Stanford University Medical Center, Stanford, Calif. 94305,
Stereotact Funct Neurosurg. 1998;71(1):43-50. doi: 10.1159/000029647.
Radiosurgery is increasingly used to treat unresectable cavernous sinus tumors. Since 1989, 24 patients with cavernous sinus meningiomas have been treated at Stanford University Medical Center with linear accelerator (LINAC) radiosurgery. The mean age of the patients was 47.8 years (range 28-78). The mean volume treated was 6. 83 cm3 (range 0.45-22.45 cm3), covered with an average of 2.3 isocenters (range 1-5). Radiation dose averaged 17.7 Gy (range 14-20 Gy). This group of patients was retrospectively studied by sending clinical questionnaires to both the patient/family and referring physicians, and reviewing clinic charts. In addition, follow-up imaging studies were obtained to measure residual tumor volume. Follow-up averaged 45.6 months (range 19-80). Tumor control (stabilization) following radiosurgery was noted in 15 (63%) and tumor shrinkage in 9 (37%). Seven meningiomas (29%) showed evidence of central tumor necrosis on MRI imaging 1-3 years after radiosurgery. Neurologic status was improved in 10 patients (42%) and unchanged in 12 patients (50%). There was 1 case of symptomatic brain necrosis and 1 case of radiation edema (asymptomatic). All other complications were transient, including 4 cases of trigeminal hypesthesia and 1 case of worsening diplopia. The 2-year actuarial tumor control rate was 100%. Although follow-up is still short, this experience corroborates prior reports that radiosurgery can be used to treat selected small cavernous sinus meningiomas with good to excellent clinical results and minimal morbidity.
放射外科越来越多地用于治疗无法切除的海绵窦肿瘤。自1989年以来,斯坦福大学医学中心已使用直线加速器(LINAC)放射外科治疗了24例海绵窦脑膜瘤患者。患者的平均年龄为47.8岁(范围288 -28-78岁)。治疗的平均体积为6.83 cm³(范围0.45-22.45 cm³),平均覆盖2.3个等中心(范围1-5个)。辐射剂量平均为17.7 Gy(范围14-20 Gy)。通过向患者/家属和转诊医生发送临床问卷,并查阅临床病历,对这组患者进行了回顾性研究。此外,还获得了随访影像学研究以测量残余肿瘤体积。随访平均45.6个月(范围19-80个月)。放射外科治疗后肿瘤得到控制(稳定)的有15例(63%),肿瘤缩小的有9例(37%)。7例脑膜瘤(29%)在放射外科治疗后1-3年的MRI成像上显示出肿瘤中心坏死的迹象。10例患者(42%)的神经状态得到改善,12例患者(50%)保持不变。有1例出现症状性脑坏死,1例出现放射性水肿(无症状)。所有其他并发症都是短暂的,包括4例三叉神经感觉减退和1例复视加重。2年的精算肿瘤控制率为100%。尽管随访时间仍然较短,但这一经验证实了先前的报道,即放射外科可用于治疗某些小型海绵窦脑膜瘤,临床效果良好至极佳,且发病率极低。